Indiana University-Purdue University Indianapolis (IUPUI)Introduction: Cancer registries collect tumor-related data to monitor incident rates and support population-based research. A common concern with using population-based registry data for research is reporting timeliness. Data timeliness have been recognized as an important data characteristic by both the Centers for Disease Control and Prevention (CDC) and the Institute of Medicine (IOM). Yet, few recent studies in the United States (U.S.) have systemically measured timeliness. The goal of this research is to evaluate the quality of cancer data and examine methods by which the reporting process can be improved. The study aims are: 1- evaluate the timeliness of cancer cases at the In...
Purpose The emphasis on early diagnosis to improve cancer survival has been a key factor in the d...
Purpose:The U.S. Food and Drug Administration and National Cancer Institute are seeking to improve m...
Background: The study startup process for interventional clinical trials is a complex process that i...
Introduction: Cancer registries collect tumor-related data to monitor incident rates and support pop...
Background Cancer registries systematically collect cancer-related data to support cancer surveilla...
Introduction: Timeliness of data availability is a key performance measure in cancer reporting. Prev...
Cancer registries must provide complete and reliable incidence information with the shortest possibl...
Background: Cancer incidence rates and trends are a mea-sure of the cancer burden in the general pop...
Background: Diagnostic timeliness in cancer patients is important for clinical outcomes and patient ...
Background/Aims: In studies of cancer incidence, it is often desirable to exclude individuals with a...
The medical community struggles with timeliness issues throughout the different healthcare environme...
Purpose: The emphasis on early diagnosis to improve cancer survival has been a key factor in the dev...
BACKGROUND: Diagnostic timeliness in cancer patients is important for clinical outcomes and patient ...
In 2012, 30,272 residents of Indiana were diagnosed with cancer. Cancer is the second leading cause...
Communicable disease reporting remains a challenging task for public health. To understand modern re...
Purpose The emphasis on early diagnosis to improve cancer survival has been a key factor in the d...
Purpose:The U.S. Food and Drug Administration and National Cancer Institute are seeking to improve m...
Background: The study startup process for interventional clinical trials is a complex process that i...
Introduction: Cancer registries collect tumor-related data to monitor incident rates and support pop...
Background Cancer registries systematically collect cancer-related data to support cancer surveilla...
Introduction: Timeliness of data availability is a key performance measure in cancer reporting. Prev...
Cancer registries must provide complete and reliable incidence information with the shortest possibl...
Background: Cancer incidence rates and trends are a mea-sure of the cancer burden in the general pop...
Background: Diagnostic timeliness in cancer patients is important for clinical outcomes and patient ...
Background/Aims: In studies of cancer incidence, it is often desirable to exclude individuals with a...
The medical community struggles with timeliness issues throughout the different healthcare environme...
Purpose: The emphasis on early diagnosis to improve cancer survival has been a key factor in the dev...
BACKGROUND: Diagnostic timeliness in cancer patients is important for clinical outcomes and patient ...
In 2012, 30,272 residents of Indiana were diagnosed with cancer. Cancer is the second leading cause...
Communicable disease reporting remains a challenging task for public health. To understand modern re...
Purpose The emphasis on early diagnosis to improve cancer survival has been a key factor in the d...
Purpose:The U.S. Food and Drug Administration and National Cancer Institute are seeking to improve m...
Background: The study startup process for interventional clinical trials is a complex process that i...